Work

Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.7561

Authors: Carrie Ho, Jonathan R. Fromm, Min Fang, Brian G. Till, Mazyar Shadman, Andrew Cowan, Ryan C. Lynch, Vicky Wu, Jenna M. Voutsinas, Heather A. Rasmussen, Katharine Blue, Chaitra Shankar Ujjani, Andrei R. Shustov, Ryan Daniel Cassaday, Ajay K. Gopal, Stephen Douglas Smith

Institutions: Fred Hutch Cancer Center, University of Washington, Seagen (United States)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4379282001

Cites:

Cited by: 1

Related to: 10